Immunocore Holdings (IMCR) Invested Capital: 2022-2025
Historic Invested Capital for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $396.6 million.
- Immunocore Holdings' Invested Capital rose 4.96% to $396.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $396.6 million, marking a year-over-year increase of 4.96%. This contributed to the annual value of $360.7 million for FY2024, which is 2.20% down from last year.
- Per Immunocore Holdings' latest filing, its Invested Capital stood at $396.6 million for Q3 2025, which was up 2.08% from $388.5 million recorded in Q2 2025.
- Over the past 5 years, Immunocore Holdings' Invested Capital peaked at $396.6 million during Q3 2025, and registered a low of $338.9 million during Q4 2022.
- In the last 3 years, Immunocore Holdings' Invested Capital had a median value of $373.3 million in 2023 and averaged $373.7 million.
- Per our database at Business Quant, Immunocore Holdings' Invested Capital rose by 8.83% in 2023 and then declined by 2.20% in 2024.
- Over the past 4 years, Immunocore Holdings' Invested Capital (Quarterly) stood at $338.9 million in 2022, then rose by 8.83% to $368.8 million in 2023, then dropped by 2.20% to $360.7 million in 2024, then increased by 4.96% to $396.6 million in 2025.
- Its Invested Capital stands at $396.6 million for Q3 2025, versus $388.5 million for Q2 2025 and $378.5 million for Q1 2025.